The company’s annual meeting resulted in the election of directors, ratification of an accounting firm, and approval of the reverse stock split amendment. More about Conduit Pharmaceuticals YTD ...
Conduit Pharmaceuticals Inc. (NASDAQ ... held on Wednesday approved an amendment allowing for a reverse stock split at a ratio of not less than 1-for-10 and not more than 1-for-100, at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback